CL2018003871A1 - Anticuerpos monoclonales específicos para el antígeno pb2 del virus de la influenza humana (flu), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por flu - Google Patents
Anticuerpos monoclonales específicos para el antígeno pb2 del virus de la influenza humana (flu), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por fluInfo
- Publication number
- CL2018003871A1 CL2018003871A1 CL2018003871A CL2018003871A CL2018003871A1 CL 2018003871 A1 CL2018003871 A1 CL 2018003871A1 CL 2018003871 A CL2018003871 A CL 2018003871A CL 2018003871 A CL2018003871 A CL 2018003871A CL 2018003871 A1 CL2018003871 A1 CL 2018003871A1
- Authority
- CL
- Chile
- Prior art keywords
- flu
- antigen
- kit
- monoclonal antibodies
- nucleotide sequences
- Prior art date
Links
- 206010022000 influenza Diseases 0.000 title 3
- 238000009007 Diagnostic Kit Methods 0.000 title 1
- 108091028043 Nucleic acid sequence Proteins 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 238000002405 diagnostic procedure Methods 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 241000712461 unidentified influenza virus Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/515—Complete light chain, i.e. VL + CL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/54—F(ab')2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/11—Orthomyxoviridae, e.g. influenza virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/10—Detection of antigens from microorganism in sample from host
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (14)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CL2018003871A CL2018003871A1 (es) | 2018-12-28 | 2018-12-28 | Anticuerpos monoclonales específicos para el antígeno pb2 del virus de la influenza humana (flu), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por flu |
| CA3125206A CA3125206A1 (en) | 2018-12-28 | 2019-12-27 | Specific monoclonal antibodies for the hepatitis pb2 of the influenza humana (flu), nucleic acid sequences; method and kit of inprol produced by flu |
| US17/418,608 US20220119503A1 (en) | 2018-12-28 | 2019-12-27 | Monoclonal antibodies specific for the pb2 antigen of the human influenza virus (flu), nucleotide sequences, method and diagnostic kit for flu infection |
| BR112021012792A BR112021012792A2 (pt) | 2018-12-28 | 2019-12-27 | Anticorpos monoclonais específicos para o antígeno pb2 do vírus da influenza humana (flu), sequências nucleotídeas, método e kit de diagnóstico de infecção produzida por flu |
| EP19905189.7A EP3904380A4 (en) | 2018-12-28 | 2019-12-27 | MONOCLONAL ANTIBODIES SPECIFIC FOR HUMAN INFLUENZA VIRUS (INFLUENZA) PB2 ANTIGEN, NUCLEOTIDE SEQUENCES; INFECTION DIAGNOSTIC METHOD AND KIT PRODUCT FOR INFLUENZA |
| ARP190103906A AR117546A1 (es) | 2018-12-28 | 2019-12-27 | Anticuerpos monoclonales específicos para el antígeno pb2 del virus de la influenza humana (flu), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por flu |
| CN201980093160.6A CN113490684A (zh) | 2018-12-28 | 2019-12-27 | 特异于人流感病毒（flu）的pb2抗原的单克隆抗体、核苷酸序列、诊断由flu产生的感染的方法和试剂盒 |
| PE2021001088A PE20211697A1 (es) | 2018-12-28 | 2019-12-27 | Anticuerpos monoclonales especificos para el antigeno pb2 del virus de la influenza humana (flu), secuencias nucleotidicas; metodo y kit de diagnostico de infeccion producida por flu |
| KR1020217024089A KR20210110662A (ko) | 2018-12-28 | 2019-12-27 | 인간 인플루엔자 바이러스(flu)의 pb2 항원에 특이적인 단일클론 항체, 뉴클레오티드 서열, flu 감염에 대한 방법 및 진단 키트 |
| PCT/CL2019/050155 WO2020132772A1 (es) | 2018-12-28 | 2019-12-27 | Anticuerpos monoclonales específicos para el antígeno pb2 del virus de la influenza humana (flu), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por flu |
| UY0001038533A UY38533A (es) | 2018-12-28 | 2019-12-27 | Anticuerpos monoclonales específicos para el antígeno pb2 del virus de la influenza humana (flu), se |
| MX2021007871A MX2021007871A (es) | 2018-12-28 | 2019-12-27 | Anticuerpos monoclonales especificos para el antigeno pb2 del virus de la influenza humana (flu), secuencias nucleotidicas; metodo y kit de diagnostico de infeccion producida por flu. |
| CONC2021/0008774A CO2021008774A2 (es) | 2018-12-28 | 2021-07-01 | Anticuerpos monoclonales específicos para el antígeno pb2 del virus de la influenza humana (flu), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por flu |
| ZA2021/04989A ZA202104989B (en) | 2018-12-28 | 2021-07-15 | Monoclonal antibodies specific for the pb2 antigen of the human influenza virus (flu), nucleotide sequences, method and diagnostic kit for flu infection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CL2018003871A CL2018003871A1 (es) | 2018-12-28 | 2018-12-28 | Anticuerpos monoclonales específicos para el antígeno pb2 del virus de la influenza humana (flu), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por flu |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2018003871A1 true CL2018003871A1 (es) | 2021-01-15 |
Family
ID=71125619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2018003871A CL2018003871A1 (es) | 2018-12-28 | 2018-12-28 | Anticuerpos monoclonales específicos para el antígeno pb2 del virus de la influenza humana (flu), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por flu |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220119503A1 (es) |
| EP (1) | EP3904380A4 (es) |
| KR (1) | KR20210110662A (es) |
| CN (1) | CN113490684A (es) |
| AR (1) | AR117546A1 (es) |
| BR (1) | BR112021012792A2 (es) |
| CA (1) | CA3125206A1 (es) |
| CL (1) | CL2018003871A1 (es) |
| CO (1) | CO2021008774A2 (es) |
| MX (1) | MX2021007871A (es) |
| PE (1) | PE20211697A1 (es) |
| UY (1) | UY38533A (es) |
| WO (1) | WO2020132772A1 (es) |
| ZA (1) | ZA202104989B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115057925B (zh) * | 2022-06-22 | 2024-03-26 | 中国检验检疫科学研究院 | 一种抗赤羽病病毒单克隆抗体及其应用 |
| CN115925891A (zh) * | 2022-07-05 | 2023-04-07 | 东莞市朋志生物科技有限公司 | 抗乙型流感病毒抗体、检测乙型流感病毒的试剂和试剂盒 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005303817B8 (en) * | 2004-11-11 | 2010-09-30 | Abbott Biologicals B.V. | Defective influenza virus particles |
| JP5725861B2 (ja) * | 2007-10-09 | 2015-05-27 | ヨーロピアン モレキュラー バイオロジー ラボラトリー | 可溶性ｒｎａキャップ結合ポケット断片、及びその使用 |
| WO2012021786A2 (en) * | 2010-08-12 | 2012-02-16 | Theraclone Sciences, Inc. | Anti-hemagglutinin antibody compositions and methods of use thereof |
| WO2012045001A2 (en) | 2010-09-30 | 2012-04-05 | Vanderbilt University | Influenza virus antibodies and immunogens and uses therefor |
| CN104098692B (zh) | 2013-04-02 | 2018-11-30 | 厦门大学 | 识别流感病毒血凝素蛋白ha1结构域的广谱单克隆抗体 |
| JP6614523B2 (ja) * | 2014-03-28 | 2019-12-04 | 地方独立行政法人神奈川県立産業技術総合研究所 | インフルエンザウイルスのｒｎａ依存性ｒｎａポリメラーゼのｐｂ２サブユニットに対するモノクローナル抗体 |
| CN107073120B (zh) * | 2014-09-22 | 2021-03-12 | 国立研究开发法人科学技术振兴机构 | 抗流感病毒剂及抗流感病毒剂的筛选方法 |
-
2018
- 2018-12-28 CL CL2018003871A patent/CL2018003871A1/es unknown
-
2019
- 2019-12-27 KR KR1020217024089A patent/KR20210110662A/ko unknown
- 2019-12-27 US US17/418,608 patent/US20220119503A1/en active Pending
- 2019-12-27 BR BR112021012792A patent/BR112021012792A2/pt unknown
- 2019-12-27 MX MX2021007871A patent/MX2021007871A/es unknown
- 2019-12-27 CA CA3125206A patent/CA3125206A1/en active Pending
- 2019-12-27 WO PCT/CL2019/050155 patent/WO2020132772A1/es unknown
- 2019-12-27 UY UY0001038533A patent/UY38533A/es unknown
- 2019-12-27 AR ARP190103906A patent/AR117546A1/es unknown
- 2019-12-27 EP EP19905189.7A patent/EP3904380A4/en active Pending
- 2019-12-27 PE PE2021001088A patent/PE20211697A1/es unknown
- 2019-12-27 CN CN201980093160.6A patent/CN113490684A/zh active Pending
-
2021
- 2021-07-01 CO CONC2021/0008774A patent/CO2021008774A2/es unknown
- 2021-07-15 ZA ZA2021/04989A patent/ZA202104989B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020132772A1 (es) | 2020-07-02 |
| CO2021008774A2 (es) | 2021-07-19 |
| EP3904380A4 (en) | 2022-05-11 |
| CA3125206A1 (en) | 2020-07-02 |
| KR20210110662A (ko) | 2021-09-08 |
| ZA202104989B (en) | 2023-01-25 |
| PE20211697A1 (es) | 2021-09-01 |
| MX2021007871A (es) | 2021-12-10 |
| CN113490684A (zh) | 2021-10-08 |
| AR117546A1 (es) | 2021-08-11 |
| US20220119503A1 (en) | 2022-04-21 |
| UY38533A (es) | 2020-07-31 |
| BR112021012792A2 (pt) | 2021-11-16 |
| EP3904380A1 (en) | 2021-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2018013500A2 (es) | Anticuerpos anti-pd-l1 y usos de los mismos | |
| CL2019000067A1 (es) | Anticuerpos nuevos que se unen específicamente a los epítopos del virus del zika y usos de los mismos. | |
| CL2017001610A1 (es) | Anticuerpos humanos para hemagglutinina de influenza | |
| CY1122804T1 (el) | Μονοκλωνικα αντισωματα εναντι ανθρωπινου αντιγονου ωριμανσης β κυτταρων (βcμα) | |
| BR112017009817A2 (pt) | anticorpos anti-il-1beta e métodos de utilização | |
| MA52003A (fr) | Procédés de traitement de maladies associées au hpv | |
| UY36905A (es) | Anticuerpos neutralizantes de poliomavirus | |
| AR106188A1 (es) | Anticuerpos anti-cd19 humano humanizados y métodos de utilización | |
| UY36942A (es) | Proteínas de unión a antígeno que activan el receptor de leptina | |
| CL2015002152A1 (es) | Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh | |
| MX2020003619A (es) | Dosificacion y administracion de los anticuerpos anti-c5 para el tratamiento de los pacientes con glomerulonefritis membranoproliferativa. | |
| ZA202104989B (en) | Monoclonal antibodies specific for the pb2 antigen of the human influenza virus (flu), nucleotide sequences, method and diagnostic kit for flu infection | |
| CU24556B1 (es) | Anticuerpos anti-basigin humanizados | |
| WO2018048317A8 (en) | Monoclonal antibodies against hemagglutinin of h5-serotype influenza viruses and their uses, hybridomas producing said antibodies, compositions and diagnostic kits | |
| UY37082A (es) | Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv | |
| CL2018003869A1 (es) | Anticuerpos monoclonales específicos para la proteína quimérica l del virus de la parainfluenza humana (piv), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por piv | |
| CL2014003373A1 (es) | Anticuerpos monoclonales especificos para el antígeno m del virus metapneumovirus humano (hmpv), producidos y secretados por hibridomas celulares , útiles para la deteccion y el diagnostico de la infeccion causada por hmpv. | |
| CL2016002046A1 (es) | Anticuerpos monoclonales específicos para el antígeno m del virus metapneumovirus humano (hmpv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por hmpv. | |
| PL409081A1 (pl) | Przeciwciała poliklonalne klasy IgY specyficzne wobec deaminazy adenozynowej oraz ich zastosowanie | |
| TH176276A (th) | พอซีนพาโวไวรัส 5b, วิธีการใช้และวัคซีน | |
| PL409845A1 (pl) | Przeciwciała poliklonalne klasy IgY specyficzne wobec peptydowego składnika ściany komórkowej bakterii oraz ich zastosowanie | |
| AR095869A1 (es) | Anticuerpos humanos que se unen a la proteína g del rsv | |
| AR098874A1 (es) | Anticuerpos caninizados | |
| TH1601003749A (th) | แอนทิบอดีชนิดโมโนคลอนัลที่ทำให้เป็นกลาง แอนทิ-il-33 ของมนุษย์ |